Antifungal agent-169
Antifungal agent-169 (compound 5p) is an antifungal agent that inhibits fluconazole (HY-B0101)-susceptible Candida albicans SC5314 with an MIC50 of 0.28 μM. Antifungal agent-169 reduces the expression levels of cAMP-PKA pathway-related genes including RAS1, EFG1, BCR1, ECE1 and HWP1 in Candida albicans. Antifungal agent-169 inhibits biofilm formation and hyphal growth of Candida albicans. Antifungal agent-169 can be used in studies related to Candida albicans infection.
For research use only. We do not sell to patients.
- Formula: C23H26ClF2N5O3S
- Molecular Weight:526.00
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antifungal agent-169 (compound 5p) potently inhibits fluconazole-sensitive Candida albicans SC5314 with an MIC50 of 0.28 μM; it also exhibits synergistic activity against Candida albicans SC5314-FR when combined with Fluconazole (HY-B0101) (FICI = 0.26)[1].
Antifungal agent-169 (0.14-0.56 μM; 96 h) exerts a sustained time-dependent inhibitory effect on the proliferation of Candida albicans SC5314[1].
Antifungal agent-169 (0.14-0.56 μM) inhibits Candida albicans biofilm formation in a concentration-dependent manner at concentrations of 0.14, 0.28, and 0.56 μM[1].
Antifungal agent-169 (0.14-0.56 μM; 4 h, 8 h) potently inhibits hyphal growth of *Candida albicans* SC5314 in Spider medium and SD + 10% FBS medium at concentrations of 0.14, 0.28 and 0.56 μM after 4 h and 8 h of treatment, and its efficacy is superior to that of fluconazole[1].
Antifungal agent-169 (0.15-5 μM; 24 h) shows no significant cytotoxicity against human bronchial epithelial 16HBE cells after treatment at concentrations up to 5 μM for 24 h, and maintains a cell viability of over 90%[1].
Antifungal agent-169 (0.14-0.56 μM) significantly downregulates the expression of cAMP-PKA pathway genes *RAS1*, *EFG1*, *BCR1*, *ECE1* and *HWP1* in *Candida albicans* SC5314[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human bronchial epithelial 16HBE cells
-
Concentration:0.15-5 μM
-
Incubation Time:24 h
-
Result:Caused no significant cytotoxicity at concentrations up to 5 μM, with cell viability remaining above 90% after 24 hours of treatment.
Chemical Information
-
Molecular Weight 526.00
-
Formula C23H26ClF2N5O3S
-
SMILES
FC1=CC=C(C(CN2CCC(NS(=O)(C3=CC=C(Cl)C=C3C)=O)CC2)(O)CN4N=CN=C4)C(F)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Filamentous Fungal Mold Culture and Sporulation
Filamentous fungal mold culture and sporulation assays grow hyphae under defined nutritional and environmental conditions until asexual spores, commonly conidia, are produced; the main readouts are colony growth, sporulation onset, conidial yield, conidial morphology, viability, and, when relevant, downstream infectivity or stress phenotype.
-
Fungal Biofilm Culture
Fungal biofilm culture is an in vitro method for growing surface-attached fungal communities, most commonly Candida albicans, on abiotic substrates such as polystyrene wells, silicone elastomer, or polymethylmethacrylate; the assay models adhesion, proliferation, filamentation, extracellular-matrix-associated maturation, and dispersion. Biofilm output can be read by optical density at 600 nm for adherent biomass, XTT reduction for metabolic activity, CFU recovery for viable attached or dispersed cells, and microscopy for architecture.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)